Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

Author's Avatar
May 04, 2023

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the first quarter ended March 31, 2023, and provided a business update.